Structural Characterization of Tau in Fuzzy Tau:Tubulin Complexes

1. Download : Download high-res image (181KB)
2. Download : Download full-size image

     

Reducing acetylated tau is neuroprotective in brain injury

1. Download : Download high-res image (138KB)
2. Download : Download full-size image

     

Exact Test Procedures for Generalized Kendall Correlation Coefficients

An exact test of KENDALL'S tau is presented, useful in small samples when the asymptotic test may not be adequate. The procedure is proposed especially for situations when ties and/or censored observations are present in the variables to be analyzed by KENDALL'S tau. The paper describes generalizations of the procedure, presents calculated examples and offers a computer program, which facilitates the usage of the proposed procedure.     

Is tau ready for admission to the prion club?

Aggregation-prone proteins associated with neurodegenerative disease, such as α synuclein and β amyloid, now appear to share key prion-like features with mammalian prion protein, such as the ability to recruit normal proteins to aggregates and to translocate between neurons. These features may shed light on the genesis of stereotyped lesion development patterns in conditions such as Alzheimer disease and Lewy Body dementia. We discuss the qualifications of tau protein as a possible “prionoid” mediator of lesion spread based on recent characterizations of the secretion, uptake and transneuronal transfer of human tau isoforms in a variety of tauopathy models, and in human patients. In particular, we consider (1) the possibility that prionoid behavior of misprocessed tau in neurodegenerative disease may involve other aggregation-prone proteins, including PrP itself, and (2) whether “prionlike” tau lesion propagation might include mechanisms other than protein-protein templating.     

The Lys 280 → Gln mutation mimicking disease‐linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties

Amyloid fibrillar aggregates isolated from the brains of patients with neurodegenerative diseases invariably have post‐translational modifications (PTMs). The roles that PTMs play in modulating the structures and polymorphism of amyloid aggregates, and hence their ability to catalyze the conversion of monomeric protein to their fibrillar structure is, however, poorly understood. This is particularly true in the case of tau aggregates, where specific folds of fibrillar tau have been implicated in specific tauopathies. Several PTMs, including acetylation at Lys 280, increase aggregation of tau in the brain, and increase neurodegeneration. In this study, tau‐K18 K280Q, in which the Lys 280 → Gln mutation is used to mimic acetylation at Lys 280, is shown, using HX‐MS measurements, to form fibrils with a structural core that is longer than that of tau‐K18 fibrils. Measurements of critical concentrations show that the binding affinity of monomeric tau‐K18 for its fibrillar counterpart is only marginally more than that of monomeric tau‐K18 K280Q for its fibrillar counterpart. Quantitative analysis of the kinetics of seeded aggregation, using a simple Michaelis–Menten‐like model, in which the monomer first binds and then undergoes conformational conversion to β‐strand, shows that the fibrils of tau‐K18 K280Q convert monomeric protein more slowly than do fibrils of tau‐K18. In contrast, monomeric tau‐K18 K280Q is converted faster to fibrils than is monomeric tau‐K18. Thus, the effect of Lys 280 acetylation on tau aggregate propagation in brain cells is expected to depend on the amount of acetylated tau present, and on whether the propagating seed is acetylated at Lys 280 or not.     

褪黑素与维生素 E 对抗花萼海绵诱癌素毒性作用的差异

最近的研究发现,褪黑素对花萼海绵诱癌素 (calyculin A , CA) 引起的骨架蛋白神经细丝异常过度磷酸化有保护作用 . 为进一步探讨褪黑素对骨架蛋白τ异常过度磷酸化的保护作用及其机制,分别用 CA, CA+ 褪黑素或 CA+ 维生素 E 处理鼠野生型成神经瘤细胞 (N2awt) ,采用 MTT 法测定细胞存活率,用免疫印迹法测定τ蛋白磷酸化水平,用 ³²P- 特异底物标记技术检测 GSK-3 和 PP-2A 活性,并进一步测定了细胞内脂质过氧化产物丙二醛含量,细胞内过氧化氢酶、超氧化物歧化酶和谷胱甘肽过氧化物酶活性 . 结果显示：褪黑素不仅对 CA 引起的抗氧化酶活性降低和脂质过氧化的保护作用强于经典抗氧化剂维生素 E ,而且对τ蛋白磷酸化的保护作用也强于经典抗氧化剂维生素 E ;褪黑素可同时激活 PP-2A 又抑制 GSK-3 ,而维生素 E 同时抑制两种酶的活性 . 研究提示：褪黑素既通过抗氧化作用,也通过调节细胞内磷酸化平衡对抗 CA 对神经细胞的毒性作用 .     

温度对不同年龄大鼠海马器官型脑片长期培养中细胞活性和tau蛋白表达的影响

探讨在海马器官型脑片的长期培养过程中,温度对不同年龄大鼠的海马脑片细胞活性和tau蛋白表达的影响,并以此为依据建立一种研究tau相关疾病的模型.选用出生后1周、2周、4周和8周的Wistar大鼠制备海马器官型脑片,培养温度分别为34℃和37℃,培养时间为21d,在培养过程中,检测培养基中的乳酸脱氢酶的含量以判断脑片的活性,采用免疫印迹技术检测细胞骨架蛋白tau的含量的变化.结果如下:(1)温度对海马脑片的细胞活性影响:34℃较37℃能在较长的时间内保持细胞活性,而在同一培养温度时,不同年龄鼠的脑片的细胞活性变化趋势一致;(2)温度对海马脑片的tau蛋白表达的影响:成年鼠(4周和8周)的海马脑片tau蛋白在34℃时能维持较长时间的稳定表达,而在37℃时tau的表达量随培养时间的延长而显著下降,且随鼠龄的增加,这种影响越明显.温度对1周和2周龄乳鼠的海马脑片tau蛋白的表达无影响.结论为:34℃培养条件下,4周和8周龄大鼠制备的海马器官型脑片能更长时间维持脑片的活性和tau蛋白的稳定表达,从而可望成为研究与tau蛋白相关疾病(如老年性痴呆)的理想模型.     

副监护子CHIP与神经退行性疾病

CHIP属于连接酶类,具有E3泛素连接酶活性,参与能量代谢途径和新陈代谢。包括阿尔茨海默病(Alzheimer'sdisease,AD)、帕金森病(Parkinson'sdisease,PD)、亨廷顿病(Huntington'sdisease,HD)等在内的神经退行性疾病的主要病理学特征之一——细胞中异常蛋白的聚集,如tau蛋白和α-突触核蛋白等,副监护子CHIP与分子伴侣,如Hsc70/Hsp70、Hsp90等相互作用对这些异常蛋白的产生具有调节作用。最近研究表明,CHIP改变了Hsc70和Hsp90介导调节的信号通路中蛋白折叠和降解的平衡,参与细胞内蛋白质的质量控制;Hsp70/CHIP伴侣系统在tau蛋白生物学和tau蛋白病理学机制中具有重要作用;CHIP可以作为α-突触核蛋白蛋白酶体降解途径和溶酶体降解途径的分子开关。这些研究进展对于进一步揭示神经退行性疾病的发病机制和研制新一代治疗药物具有重要的作用。